Lu Li
Stock Analyst at UBS
(1.44)
# 3,502
Out of 5,180 analysts
15
Total ratings
66.67%
Success rate
-3.24%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lu Li
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MYGN Myriad Genetics | Maintains: Neutral | $8 → $6 | $4.36 | +37.61% | 5 | Feb 24, 2026 | |
| QDEL QuidelOrtho | Maintains: Neutral | $31 → $35 | $15.26 | +129.36% | 4 | Jan 21, 2026 | |
| VCYT Veracyte | Maintains: Buy | $42 → $48 | $30.44 | +57.69% | 5 | Nov 5, 2025 | |
| FLGT Fulgent Genetics | Upgrades: Buy | $20 → $30 | $15.63 | +91.94% | 1 | Aug 5, 2025 |
Myriad Genetics
Feb 24, 2026
Maintains: Neutral
Price Target: $8 → $6
Current: $4.36
Upside: +37.61%
QuidelOrtho
Jan 21, 2026
Maintains: Neutral
Price Target: $31 → $35
Current: $15.26
Upside: +129.36%
Veracyte
Nov 5, 2025
Maintains: Buy
Price Target: $42 → $48
Current: $30.44
Upside: +57.69%
Fulgent Genetics
Aug 5, 2025
Upgrades: Buy
Price Target: $20 → $30
Current: $15.63
Upside: +91.94%